Brian Gallagher

Trekk Venture Partners is a venture capital company that develops life-changing medicines.

Effector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.

Raised $242,522,514.00 from The Column Group, Alexandria Venture Investments, Altitude Life Science Ventures, Abingworth, SR One, BioMed Ventures, Sectoral Asset Management, OUP (Osage University Partners), U.S. Venture Partners and Pfizer Venture Investments.

Q32 Bio is a biotechnology company that develops treatments for patients with severe autoimmune and inflammatory diseases.

Raised $148,000,000.00 from OrbiMed, Homology Medicines, Bristol-Myers Squibb, Atlas Venture, Agent Capital, Acorn Bioventures, Sanofi Ventures, The CU Healthcare Innovation Fund, Abingworth and OUP (Osage University Partners).

Navitor Pharma is a developer of novel medicines designed to target specific nutrient-sensing proteins to treat diseases.

Raised $98,168,747.00 from SR One, Sanofi Ventures, Remeditex Ventures, Atlas Venture, Polaris Partners, Brace Pharma and Johnson & Johnson Robotics and Digital Solutions.